Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Compremium AG
- Study ID
- NCT06885073
- Status
- Recruiting
Conditions
- Central Venous Pressure
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- CPMX2 — DEVICECPMX2 - Non-invasive pressure estimation
Study Details
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
Key Dates
- Start date
- Mar 10, 2025
- Status verified
- Sep 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: CPMX2 measurement armCPMX2 measurements will be compared against invasive CVP measurements
Primary Outcome Measure
Safety of external jugular venous occlusion pressure measured non-invasively with CPMX2 to estimate CVP in pediatric patients. [ Time Frame: Up to 4 days ]
Central Contacts
- Damon Judges+41775071995
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | - |